Alector signs exclusive global licensing deal with Genentech for Parkinson's treatment, receiving $100 million upfront.

Observed price moves

• ALEC+7.81%10 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.